Holen Sie sich die Stockscreener-App
25.32
4.81%
1.21
Schlusskurs vom Vortag:
$24.11
Offen:
$24.6
24-Stunden-Volumen:
229.98K
Relative Volume:
0.27
Marktkapitalisierung:
$2.12B
Einnahmen:
$23.38M
Nettoeinkommen (Verlust:
$-155.22M
KGV:
-11.56
EPS:
-2.19
Netto-Cashflow:
$-134.36M
1W Leistung:
+5.56%
1M Leistung:
-2.81%
6M Leistung:
-31.68%
1J Leistung:
-42.03%
1-Tages-Spanne:
$24.45
$25.59
1-Wochen-Bereich:
$23.29
$25.59
52-Wochen-Spanne:
$22.10
$47.73
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Firmenname
Ideaya Biosciences Inc
Sektor
Branche
Telefon
650-443-6209
Adresse
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie IDYA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
25.34 | 2.12B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
487.05 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
706.73 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
667.46 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.44 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.67 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-18 | Eingeleitet | Stephens | Overweight |
| 2024-11-05 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Eingeleitet | Mizuho | Outperform |
| 2024-03-08 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | SVB Securities | Outperform |
| 2023-05-24 | Eingeleitet | Goldman | Buy |
| 2023-04-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-23 | Eingeleitet | Berenberg | Buy |
| 2023-02-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-28 | Eingeleitet | CapitalOne | Overweight |
| 2022-10-27 | Eingeleitet | Citigroup | Buy |
| 2022-08-15 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-23 | Eingeleitet | Stifel | Hold |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-11 | Eingeleitet | Guggenheim | Buy |
| 2020-10-07 | Eingeleitet | Wedbush | Outperform |
| 2020-09-01 | Eingeleitet | Northland Capital | Outperform |
| 2020-07-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-17 | Eingeleitet | Citigroup | Buy |
| 2019-06-17 | Eingeleitet | JP Morgan | Neutral |
| 2019-06-17 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten
Take off with Ideaya Biosciences Inc (IDYA): Get ready for trading - SETE News
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
SG Americas Securities LLC Boosts Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
IDYAIDEAYA Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
IDEAYA Awards Strategic Stock Options Package: Key Details for New Hires Revealed - StockTitan
12 Stocks That Will Double in 2025 - Insider Monkey
Uncover the Top 12 Stocks Set to Skyrocket by 2025! - Reporteros del Sur -
Here’s Why IDEAYA Biosciences, Inc. (IDYA) Will Double in 2025 - Insider Monkey
BTIG reiterates Buy on Ideaya stock, cites significant updates - MSN
Mizuho Initiates Coverage of IDEAYA Biosciences (IDYA) with Outperform Recommendation - MSN
IDEAYA Biosciences to Participate in Upcoming February 2025 Investor Relations Events - Nasdaq
IDEAYA Biosciences to Present at Major Healthcare Investment Conferences - StockTitan
(IDYA) Technical Data - Stock Traders Daily
Here's Why We're Not Too Worried About IDEAYA Biosciences' (NASDAQ:IDYA) Cash Burn Situation - Yahoo Finance
Cantor Fitzgerald Weighs in on IDYA FY2025 Earnings - Defense World
Brokers Issue Forecasts for IDYA FY2025 Earnings - MarketBeat
BTIG reiterates Buy on Ideaya stock, cites significant updates By Investing.com - Investing.com Canada
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Stock Holdings Lifted by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Grows Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat
Ideaya stock touches 52-week low at $22.15 amid market challenges - MSN
Short Interest in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Expands By 10.1% - MarketBeat
IDEAYA Biosciences (IDYA): A Down Year Presents a Window of Opportunity for Investors - MSN
IDEAYA Biosciences (NASDAQ:IDYA) Hits New 1-Year LowHere's Why - MarketBeat
IDEAYA Biosciences’ (IDYA) “Outperform” Rating Reiterated at Royal Bank of Canada - Defense World
Ideaya stock touches 52-week low at $22.15 amid market challenges By Investing.com - Investing.com South Africa
Leerink Partners Downgrades IDEAYA Biosciences (IDYA) - MSN
Learn to Evaluate (IDYA) using the Charts - Stock Traders Daily
Royal Bank of Canada Reaffirms "Outperform" Rating for IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
IDEAYA Biosciences (NASDAQ:IDYA) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance - Marketscreener.com
IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance – Company Announcement - Financial Times
IDEAYA Biosciences (NASDAQ:IDYA) Hits New 12-Month Low – Here’s Why - Defense World
IDEAYA Biosciences Unveils Ambitious 2025 Growth Plan, $1.2B Cash Position Funds Through 2028 - StockTitan
Ideaya Biosciences stock hits 52-week low at $24.14 By Investing.com - Investing.com Australia
IDEAYA Biosciences (NASDAQ:IDYA) Reaches New 1-Year LowShould You Sell? - MarketBeat
Ideaya Biosciences stock hits 52-week low at $24.14 - Investing.com
Analysts Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Price Target at $53.67 - MarketBeat
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
IDEAYA Biosciences' SWOT analysis: oncology biotech stock's potential and risks - Investing.com Australia
IDEAYA Biosciences' SWOT analysis: oncology biotech stock's potential and risks By Investing.com - Investing.com South Africa
Principal Financial Group Inc. Sells 4,968 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
IDEAYA Biosciences (NASDAQ:IDYA) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Another Major DLL3 ADC Alliance As Hengrui Links With IDEAYA - Citeline
Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals - BioPharma Dive
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
3.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):